Breast Cancer Therapy
Research conducted at Hamilton College, Department of Chemistry has provided new information about breast cancer therapy
Published in Gene Therapy Weekly, June 14th, 2007
Investigators publish new data in the report "Computational design and experimental discovery of an antiestrogenic peptide derived from alpha-fetoprotein." According to a study from the United States, "Breast cancer is the most common cancer among women, and tamoxifen is the preferred drug for estrogen receptor-positive breast cancer treatment. Many of these cancers are intrinsically resistant to tamoxifen or acquire resistance during treatment."
"Consequently, there is an ongoing need for breast cancer drugs that have different molecular targets. Previous work has shown that 8-mer and cyclic 9-mer peptides inhibit breast cancer in mouse and rat models, interacting with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-06-14)
More Articles from Gene Therapy Weekly
- Amyotrophic Lateral Sclerosis
Researchers Have New Insight into Cause of Lou Gehrig’s Disease - Gene Therapy
Gene therapy delivery of nerve growth factors reverses erectile dysfunction in animal model - Cancer Vaccines
Inovio Biomedical's DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results - Gene Therapy
Amsterdam Molecular Therapeutics Appoints Ferdinand Verdonck as Chairman of the Supervisory Board - Gene Therapy
Significant Scientific Breakthrough in Stem Cell Banking - Gene Therapy
Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
